| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(9 years from now) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(9 years from now) | |
Esmolol Hydrochloride Double Strength In Plastic Container is owned by Hq Spclt Pharma.
Esmolol Hydrochloride Double Strength In Plastic Container contains Esmolol Hydrochloride.
Esmolol Hydrochloride Double Strength In Plastic Container has a total of 2 drug patents out of which 0 drug patents have expired.
Esmolol Hydrochloride Double Strength In Plastic Container was authorised for market use on 07 April, 2016.
Esmolol Hydrochloride Double Strength In Plastic Container is available in solution;intravenous dosage forms.
The generics of Esmolol Hydrochloride Double Strength In Plastic Container are possible to be released after 15 March, 2033.
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic